Cargando…

Minocycline corrects early, pre-plaque neuroinflammation and inhibits BACE-1 in a transgenic model of Alzheimer's disease-like amyloid pathology

BACKGROUND: A growing body of evidence indicates that inflammation is one of the earliest neuropathological events in Alzheimer's disease. Accordingly, we have recently shown the occurrence of an early, pro-inflammatory reaction in the hippocampus of young, three-month-old transgenic McGill-Thy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferretti, Maria Teresa, Allard, Simon, Partridge, Vanessa, Ducatenzeiler, Adriana, Cuello, A Claudio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352127/ https://www.ncbi.nlm.nih.gov/pubmed/22472085 http://dx.doi.org/10.1186/1742-2094-9-62

Ejemplares similares

Rescue of Early bace-1 and Global DNA Demethylation by S-Adenosylmethionine Reduces Amyloid Pathology and Improves Cognition in an Alzheimer’s Model
por: Do Carmo, Sonia, et al.
Publicado: (2016)

Intracellular Aβ pathology and early cognitive impairments in a transgenic rat overexpressing human amyloid precursor protein: a multidimensional study
por: Iulita, M Florencia, et al.
Publicado: (2014)

BACE1 inhibition by microdose lithium formulation NP03 rescues memory loss and early stage amyloid neuropathology
por: Wilson, E N, et al.
Publicado: (2017)

BACE1 Function and Inhibition: Implications of Intervention in the Amyloid Pathway of Alzheimer’s Disease Pathology
por: Koelsch, Gerald
Publicado: (2017)

Minocycline alleviates beta-amyloid protein and tau pathology via restraining neuroinflammation induced by diabetic metabolic disorder
por: Cai, Zhiyou, et al.
Publicado: (2013)

The Alzheimer’s β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques
por: Kandalepas, Patty C., et al.
Publicado: (2013)

Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice
por: Heneka, Michael T, et al.
Publicado: (2005)

Erratum to: The Alzheimer’s β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques
por: Kandalepas, Patty C., et al.
Publicado: (2013)

A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice
por: Neumann, Ulf, et al.
Publicado: (2015)

Icariin Decreases the Expression of APP and BACE-1 and Reduces the β-amyloid Burden in an APP Transgenic Mouse Model of Alzheimer's Disease
por: Zhang, Lan, et al.
Publicado: (2014)

Antibody-Based In Vivo PET Imaging Detects Amyloid-β Reduction in Alzheimer Transgenic Mice After BACE-1 Inhibition
por: Meier, Silvio R., et al.
Publicado: (2018)

Modeling Alzheimer’s disease in transgenic rats
por: Do Carmo, Sonia, et al.
Publicado: (2013)

Cerebrospinal Fluid BACE1 Activity and Brain Amyloid Load in Alzheimer's Disease
por: Grimmer, Timo, et al.
Publicado: (2012)

Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer’s disease
por: Sadleir, Katherine R., et al.
Publicado: (2016)

Extracellular protein components of amyloid plaques and their roles in Alzheimer’s disease pathology
por: Rahman, M. Mahafuzur, et al.
Publicado: (2021)

Intravenous Injection of PHF-Tau Proteins From Alzheimer Brain Exacerbates Neuroinflammation, Amyloid Beta, and Tau Pathologies in 5XFAD Transgenic Mice
por: Houben, Sarah, et al.
Publicado: (2020)

Strategy to enhance transgene expression in proximity of amyloid plaques in a mouse model of Alzheimer's disease
por: Weber-Adrian, Danielle, et al.
Publicado: (2019)

Collagenous Alzheimer amyloid plaque component impacts on the compaction of amyloid-β plaques
por: Hashimoto, Tadafumi, et al.
Publicado: (2020)

Editorial: The Involvement of NGF in the Alzheimer's Pathology
por: Cuello, A. Claudio
Publicado: (2019)

The effect of electroconvulsive therapy on neuroinflammation, behavior and amyloid plaques in the 5xFAD mouse model of Alzheimer’s disease
por: Svensson, Martina, et al.
Publicado: (2021)

Tau deletion reduces plaque‐associated BACE1 accumulation and decelerates plaque formation in a mouse model of Alzheimer's disease
por: Peters, Finn, et al.
Publicado: (2019)

Triptolide treatment reduces Alzheimer’s disease (AD)-like pathology through inhibition of BACE1 in a transgenic mouse model of AD
por: Wang, Qi, et al.
Publicado: (2014)

PS1 Affects the Pathology of Alzheimer’s Disease by Regulating BACE1 Distribution in the ER and BACE1 Maturation in the Golgi Apparatus
por: Li, Nuomin, et al.
Publicado: (2022)

Experimental Pharmacology in Transgenic Rodent Models of Alzheimer’s Disease
por: Cuello, A. Claudio, et al.
Publicado: (2019)

A combination Alzheimer’s therapy targeting BACE1 and neprilysin in 5XFAD transgenic mice
por: Devi, Latha, et al.
Publicado: (2015)

miRNA-31 Improves Cognition and Abolishes Amyloid-β Pathology by Targeting APP and BACE1 in an Animal Model of Alzheimer’s Disease
por: Barros-Viegas, Ana Teresa, et al.
Publicado: (2020)

Reduced β-amyloid pathology in an APP transgenic mouse model of Alzheimer’s disease lacking functional B and T cells
por: Späni, Claudia, et al.
Publicado: (2015)

Lack of α-synuclein increases amyloid plaque accumulation in a transgenic mouse model of Alzheimer's disease
por: Kallhoff, Verena, et al.
Publicado: (2007)

Quinacrine directly dissociates amyloid plaques in the brain of 5XFAD transgenic mouse model of Alzheimer’s disease
por: Park, Sohui, et al.
Publicado: (2021)

The effect of BACE1-AS on β-amyloid generation by regulating BACE1 mRNA expression
por: Li, Fan, et al.
Publicado: (2019)

Heparan sulfate regulates amyloid precursor protein processing by BACE1, the Alzheimer's β-secretase
por: Scholefield, Zoe, et al.
Publicado: (2003)

Focal-type, but not Diffuse-type, Amyloid Beta Plaques are Correlated with Alzheimer’s Neuropathology, Cognitive Dysfunction, and Neuroinflammation in the Human Hippocampus
por: Liu, Fan, et al.
Publicado: (2022)

BACE1 inhibition more effectively suppresses initiation than progression of β-amyloid pathology
por: Peters, Finn, et al.
Publicado: (2018)

Pathological changes induced by Alzheimer’s brain inoculation in amyloid-beta plaque-bearing mice
por: Lam, Suzanne, et al.
Publicado: (2022)

Effects of human intravenous immunoglobulin on amyloid pathology and neuroinflammation in a mouse model of Alzheimer’s disease
por: Puli, Lakshman, et al.
Publicado: (2012)

Memory deficiency, cerebral amyloid angiopathy, and amyloid-β plaques in APP+PS1 double transgenic rat model of Alzheimer’s disease
por: Klakotskaia, Diana, et al.
Publicado: (2018)

Detection of Amyloid Plaques Targeted by Bifunctional USPIO in Alzheimer’s Disease Transgenic Mice Using Magnetic Resonance Microimaging
por: Wadghiri, Youssef Zaim, et al.
Publicado: (2013)

Intranasal Delivery of Collagen-Loaded Neprilysin Clears Beta-Amyloid Plaques in a Transgenic Alzheimer Mouse Model
por: Humpel, Christian
Publicado: (2021)

Tetramodal Chemical Imaging Delineates the Lipid–Amyloid Peptide Interplay at Single Plaques in Transgenic Alzheimer’s Disease Models
por: Ge, Junyue, et al.
Publicado: (2023)

Cellulose ether treatment inhibits amyloid beta aggregation, neuroinflammation and cognitive deficits in transgenic mouse model of Alzheimer’s disease
por: Ali, Tahir, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ihtdkh0a50alk79fl5mek6cdrb